APOL1 Gene and African-American Susceptibility to Chronic Kidney Disease by John Sedor, MD

Health Inequities, APOL1, and Chronic Kidney Disease in African Americans and BlacksПодробнее

APOL1-Associated Nephropathy: Pathology, Mechanisms, and Clinical Utility - Dr. Barry FreedmanПодробнее

APOL1 and Chronic Kidney Disease: Advances and ChallengesПодробнее

Understanding Genetic Kidney Disease: Insights on the APOL-1 GeneПодробнее

Role of the APOL1 Gene in Kidney Disease | Barry Freedman, MDПодробнее

Understanding Genetic Kidney Diseases Insights Into APOL1Подробнее

APOL1-mediated kidney disease | Rare Kidney Disease | AKFПодробнее

NMQF Webinar: Understanding Genetic Kidney Diseases: Insights into APOL1Подробнее

“APOL1 Plus” Genotypes in Patients with Chronic Kidney Disease | ASN AbstractПодробнее

Gutiérrez et al; APOL1 Risk Variants and CVDПодробнее

Advances in APOL1 TherapeuticsПодробнее

Emerging Research with Global Implications: Identification & Diagnosis of Kidney Diseases - APOL1Подробнее

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex PharmaceuticalsПодробнее

APOL1-Mediated Kidney DiseaseПодробнее

Recent Breakthroughs with the APOL1 Nephropathy Gene Risk VariantПодробнее

Genetic Kidney Disease in African Americans – Treating the Underlying CauseПодробнее

Daniel Watford, MD, MPH - APOL1 Kidney Risk Variants and the APOLLO StudyПодробнее

APOL1 & Kidney Disease: Progress Toward Precision Medicine | DoM Grand Rounds | 30 March 2022Подробнее

Understanding Genetic Kidney Diseases Insights: Insights into APOL1Подробнее